Filed pursuant to Rule 424(b)(3)
1933 Act File No. 333-269139
PROSPECTUS SUPPLEMENT dated January
31, 2024
(to Prospectus dated June 9, 2023, as supplemented from time to time)
EAGLE POINT CREDIT COMPANY INC.
$225,000,000 of Common Stock
Up to 800,000 Shares of 6.50% Series C Term Preferred Stock due 2031
Liquidation Preference $25 per share
Up to 1,000,000 Shares of 6.75% Series D Preferred Stock
Liquidation Preference $25 per share
This prospectus supplement supplements the prospectus supplement dated June 12, 2023, or the “Supplement,” and the accompanying prospectus thereto dated June 9, 2023, or the “Base Prospectus.” The Base Prospectus and Supplement, and all supplements to or documents incorporated by reference into the Base Prospectus and Supplement, are collectively referred to as the “Prospectus.” The Prospectus relates to the offering of shares of our common stock, par value $0.001 per share, our 6.50% Series C Term Preferred Stock due 2031, and our 6.75% Series D Preferred Stock in an “at-the-market” offering pursuant to the Third Amended and Restated At Market Issuance Sales Agreement, dated June 12, 2023, with B. Riley Securities, Inc., or the “Sales Agreement.”
Investing in our securities involves a high degree of risk, including the risk of a substantial loss of investment. Before purchasing any shares of our common stock or preferred stock, you should read the discussion of the principal risks of investing in our securities, which are summarized in “Risk Factors” beginning on page S-17 of the Supplement and page 13 of the Base Prospectus, as well as in other documents incorporated by reference into the Prospectus.
The terms “Company,” “we,” “us” and “our” refer to Eagle Point Credit Company Inc., a Delaware corporation.
UPDATE TO “AT-THE-MARKET” OFFERING
Effective as of the date of this prospectus supplement, the Company updated the amount of shares of its 6.75% Series D Preferred Stock to be sold pursuant to the Sales Agreement from 200,000 to 1,000,000 shares, representing an aggregate liquidation preference of $25,000,000 (inclusive of any shares of 6.75% Series D Preferred Stock previously sold pursuant to the Sales Agreement).